
Sign up to save your podcasts
Or
Send us a text
Welcome to Episode 16 in our Experts On Point podcast series brought to you by The Oncology Podcast.
What is adaptive therapy? How has evolutionary game theory inspired a new approach to prostate cancer treatment? How can non-disruptive creation mitigate administrative pitfalls in clinical research?
Join our Host Rachael Babin in conversation with Associate Professor Craig Gedye to learn about the fascinating and radical new ANZadapt trial for metastatic castrate-resistant prostate cancer.
We hope you enjoy listening.
For news and podcast updates subscribe to The Oncology Newsletter, a free weekly publication for healthcare professionals with an interest in oncology. Click here to subscribe.
PART OF THE ONCOLOGY NETWORK... Join Us
5
44 ratings
Send us a text
Welcome to Episode 16 in our Experts On Point podcast series brought to you by The Oncology Podcast.
What is adaptive therapy? How has evolutionary game theory inspired a new approach to prostate cancer treatment? How can non-disruptive creation mitigate administrative pitfalls in clinical research?
Join our Host Rachael Babin in conversation with Associate Professor Craig Gedye to learn about the fascinating and radical new ANZadapt trial for metastatic castrate-resistant prostate cancer.
We hope you enjoy listening.
For news and podcast updates subscribe to The Oncology Newsletter, a free weekly publication for healthcare professionals with an interest in oncology. Click here to subscribe.
PART OF THE ONCOLOGY NETWORK... Join Us
878 Listeners
43,822 Listeners
109 Listeners
621 Listeners
55 Listeners
197 Listeners
546 Listeners
10,124 Listeners
166 Listeners
20,649 Listeners
37 Listeners
7,395 Listeners
509 Listeners